최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기약학회지 = Yakhak hoeji, v.56 no.1, 2012년, pp.48 - 54
Enviromental differences in gentamicin pharmacokinetics by using population pharmacokinetic methods were compared with 20 Korean patients and 24 Korean-American appendicitis patients. Two to six blood specimens were collected from all patients at the following times : just before a regularly schedul...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
환자간의 개체차에는 어떤것이 있는가? | 임상에서 환자 개개인에 대해 투여설계를 해야하는 이유는 환자간의 개체차가 있기 때문이다. 즉 나이, 체중, 신장 및 성별이 다르며, 신 및 간장 기능의 차이가 있으며 또한 흡연, 음주, 식사등 차이가 있다. 이러한 개체차는 한국인과 미국에서 사는 재미 동포의 경우, 두 집단의 다른 환경이 또한 영향을 줄 수 있다. | |
임상에서 환자 개개인에 대해 투여설계를 해야하는 이유는? | 임상에서 환자 개개인에 대해 투여설계를 해야하는 이유는 환자간의 개체차가 있기 때문이다. 즉 나이, 체중, 신장 및 성별이 다르며, 신 및 간장 기능의 차이가 있으며 또한 흡연, 음주, 식사등 차이가 있다. | |
임상약물동태학에서 우리나라에서는 무엇을 이용하는가? | 임상약물동태학(clinical pharmacokinetic consultation service)에서 환자 개개인에 대한 투여계획을 위해 우리나라에서는 Bayesian 약물동태학 프로그램이 주로 이용되고 있으나, 이 Bayesian법을 위한 모집단 약물동태학적 변수로 외국인의 변수를 많이 사용하고 있다. 겐타마이신은 그람음성 감염증에 전세계적으로 폭넓게 사용되는 아미노배당체 항생제13)로 신장 및 청각장애 등의 부작용으로 빈번하게 나타나는 약물이다. |
Sheiner, B. B., Beal, S., Rosenberg, B. and Marathe, V. V. : Forecasting individual pharmacokinetics. Clin. Pharmacol. Ther. 31, 294 (1979).
Hurst, A., Yoshinaga, M., Mitani, G., Foo, K., Jelliffe, R. W. and Harrison, E. : Application of a bayesian method to monitor and adjust vancomycin dosage regimens. Antimicrob. Agents Chemother. 34, 1165 (1990).
Touw, D. J., Proost, J. H., Stevens, R., Lafeber, H. N. and van Weissenbruch, M. M. : Gentamicin pharmacokinetics in preterm infants with a patent and a closed ductus arteriosus. Pharm. World Sci. 23, 200 (2001).
Nielsen, E. I., Sandstrom, M., Honore, P. H., Ewald, U. and Friberg, L. E. : Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study. Clin. Pharmacokinet. 48, 253 (2009).
Seaton, C., Ignas, J., Muchohi, S., Kokwaro, G., Maitland, K. and Thomson, A. H. : Population pharmacokinetics of a single daily intramuscular dose of gentamicin in children with severe malnutrition. J. Antimicrob. Chemother. 59, 681 (2007).
Garcia, B., Barcia, E., Perez, F. and Molina, I. T. : Population pharmacokinetics of gentamicin in premature newborns. J. Antimicrob. Chemother. 58, 372 (2006).
Xuan, D., Nicolau, D. P. and Nightingale, C. H. : Population pharmacokinetics of gentamicin in hospitalized patients receiving once-daily dosing. Int. J. Antimicrob. Agents 23, 291 (2004).
Treluyer, J. M., Merle, Y., Tonnelier, S., Rey, E. and Pons, G. : Nonparametric population pharmacokinetic analysis of amikacin in neonates, infants, and children. Antimicrob. Agents Chemother. 46, 1381 (2002).
Biggeri, A., Marchi, M., Lagazio, C., Martuzzi, M. and Bohning, D. : Non-parametric maximum likelihood estimators for disease mapping. Stat. Med. 15, 2539 (2000).
Bustad, A., Terziivanov, D., Leary, R., Port, R., Schumitzky, A. and Jelliffe, R. : Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies. Clin. Pharmacokinet. 45, 365 (2006).
Stolk, L. M., Degraeuwe, P. L., Nieman, F. H., de Wolf, M. C. and de Boer, A. : Population pharmacokinetics and relationship between demographic and clinical variables and pharmacokinetics of gentamicin in neonates. Ther. Drug. Monit. 24, 527 (2002).
Rougier, F., Claude, D., Maurin, M., Sedoglavic, A., Ducher, M., Corvaisier, S., Jelliffe, R. and Maire, P. : Aminoglycoside nephrotoxicity: modeling, simulation, and control. Antimicrob. Agents Chemother. 47, 1010 (2003).
Garrison, M. W., Zaske, D. E. and Rotschafer, J. C. : Aminoglycosides: another perspective. Ann. Pharmacother. 24, 267 (1990).
Burm, J. P. : The influence of weight with assay error on gentamicin pharmacokinetics using the Bayesian and nonlinear least square regression analysis in appendicitis patients. Biopharm. Drug Dispos. 26, 189 (2005).
Jelliffe, R. W., D'Argenio, D. Z., Schumitzky, A., Hu, L. and Liu, M. : The $USC^*$ PACK PC programs for planning, monitoring and adjusting drug dosage regimens. Proceedings of the twenty-third annual meeting of the Association for the Advancement of Medical Instrumentation. Washington, DC, May, p. 13 (1988).
Press, S. J. : Bayesian statistics: Principles, models, and application. John Wiley & Sons, Inc., Appendices 1-4, p. 175 (1989).
Jelliffe, R. W. and Schumitzky, A. : User manual for the nonparametric EM program for population pharmacokinetic modeling version 1. University of Southern California, School of Medicine, Los Angeles, Calfornia (1989).
Sawchuk, R. J. and Zaske, D. E. : Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: Gentamicin in burn patients. J. Pharmacokinet. Biopharm. 4, 183 (1976).
Vercaigne, L. M., Ariano, R. E. and Zacharias, J. M. : Bayesian pharmacokinetics of gentamicin in a haemodialysis population. Clin. Pharmacokinet. 43, 205 (2004).
Jelliffe, R. W., Iglesias, T., Hurst, A., Foo, K. and Rodriguez, J. : Individualizing gentamicin dosage regimens. A comparative review of selected models, data fitting methods and monitoring stategies. Clin. Pharmacokinet. 21, 461 (1991).
Erdmann, S. M., Rodvold, K. A. and Pryka, R. D. : An updated comparison of drug dosing methods. Part III: amionglycoside antibiotics. Clin. Pharmacokinet. 20, 374 (1991).
Thomson, A. H. and Whiting, B : Bayesian parameter estimation and population pharmacokinetics. Clin. Pharmacokinet. 22, 447 (1992).
Jelliffe, R. W., Schumitzky, A. and Van Guilder, M. : Nonpharmacokinetic factors affecting aminoglycoside therapeutic precision: A simulation study. Drug Invest. 4, 20 (1992).
Antal, E. J., Grasela, T. H. and Smith, R. B. : An evaluation of population pharmacokinetics in therapeutic trials. Part III: prospective data collection versus retrospective data assembly. Clin. Pharmacol. Ther. 46, 552 (1989).
Gan, S. H., Ismail, R., Wan Adnan, W. A., Zulmi, W. and Jelliffe, R. W. : Population pharmacokinetic modelling of tramadol with application of the NPEM algorithms. J. Clin. Pharm. Ther. 29, 455 (2004).
Beal, S. : Population pharmacokinetic data and parameter estimation based on their first two statistical moments. Drug Metab. Rev. 16, 173 (1984).
Beal, S. : Asymptotic properties of optimization estimates for the independent net identically distributed case with application to extended least-squares estimate. Technical report of the Division of Clinical Pharmacology. University of Califormia, San Francisco (1984).
Mallet, A. : A maximum likelihood estimation method for random coefficient regression models. Biometrika 73, 645 (1986).
Mallet, A., Mentre, F., Steimer, J. L. and Lookiec, F. : Nonparametric maxmum likelihood estimation for population pharmacokinetics with application to cyclosporine. J. Pharmacokinet. Biopharm. 16, 311 (1988).
Dodge, W. F., Jelliffe, R. W., Richardson, C. J. and McCleery, R. A. : Gentamicin population pharmacokinetic models for low birth weight infants using a new nonparametric method. Clin. Pharmacol. Ther. 50, 25 (1991).
Bond, W. S. : Ethnicity and psychotropic drugs. Clin. Pharm. 10, 467 (1991).
Wood, A. and Zhou, H. : Ethnic differences in drug disposition and responsiveness. Clin. Pharmacokinet. 20, 350 (1991).
Jhee, S. S., Burm, J. P. and Gill, M. A. : Comparison of aminoglycoside pharmacokinetics in asian, hispanic and caucasian patient using population pharmacokinetic methods. Antimicrob. Agents Chemother. 38, 2073 (1994).
Botha, J. H., du Preez, M. J. and Adhikari, M. : Population pharmacokinetics of gentamicin in South African newborns. Eur. J. Clin. Pharmacol. 59. 755 (2003).
※ AI-Helper는 부적절한 답변을 할 수 있습니다.